Laxman Bahroo, DO

The professor of neurology and resident program director at MedStar Georgetown University Hospital discussed how Parkinson disease motor fluctuations are managed amid new, novel technologies incorporated in the field. [WATCH TIME: 4 minutes]

The professor of neurology and residency program director at MedStar Georgetown University Hospital spoke to the evolution of the utility of botulinumtoxins in the treatment of patients with Parkinson and other movement disorders. [WATCH TIME: 4 minutes]

The professor of neurology and residency program director at MedStar Georgetown University Hospital discussed the value of educating clinicians on the utility of botulinumtoxins in PD care. [WATCH TIME: 3 minutes]

The holy grail of neurodegenerative disorders would be to alter or halt the progression of the disease. For years, the discussion has swirled around stem cells and gene therapy, and they remain potential options for the future.

The assistant professor of neurology and codirector of the Neurology Residency Program at MedStar Georgetown University Hospital and presenter at ATMRD offered his insight into the benefits of multispecialty meetings. [WATCH TIME: 1 minute]

The assistant professor of neurology and codirector of the Neurology Residency Program at MedStar Georgetown University Hospital and presenter at ATMRD offered his insight into the benefits of multispecialty meetings. [WATCH TIME: 3 minutes]

Drs Laxman Bahroo, Rajesh Pahwa, and Robert A. Hauser share advice for neurologists treating OFF episodes in Parkinson Disease.

Robert A. Hauser, MD, MBA; Laxman Bahroo, DO; and Rajesh Pahwa, MD, review emerging therapies in development for the management of OFF episodes in Parkinson Disease.

Experts in movement disorders explore the potential role of an apomorphine infusion device in the Parkinson Disease treatment landscape for patients suffering from OFF episodes.

The assistant professor of neurology and codirector of the Neurology Residency Program at MedStar Georgetown University Hospital shared his thoughts on the 2022 ATMRD Congress and the steps forward made in patient awareness of therapeutic options. [WATCH TIME: 3 minutes]

Robert A. Hauser, MD, MBA, and Rajesh Pahwa, MD, highlight novel administration routes for the management of OFF episodes in patients with Parkinson disease.

Laxman Bahroo, DO, examines the effectiveness of on-demand therapies to manage OFF episodes in Parkinson disease and highlights the importance of frequent monitoring and follow-up visits.

Rajesh Pahwa, MD, comments on the different routes of administration of on-demand therapies and medication absorption for the management of OFF episodes in Parkinson disease.

Robert A. Hauser, MD, MBA, and Laxman Bahroo, DO, review unmet needs in managing OFF episodes for patients with Parkinson Disease.

Rajesh Pahwa, MD, provides insight on initiating treatment after the manifestation of OFF episodes and reviews current treatment options for Parkinson disease.

Drs Robert A. Hauser, Rajesh Pahwa, and Laxman Bahroo discuss factors to consider when approaching treatment selection for managing OFF episodes in Parkinson Disease.

Experts in movement disorders share the importance of multidisciplinary team collaboration for the management of OFF episodes and shared-decision making for treating Parkinson disease.

Robert A. Hauser, MD, MBA, and Rajesh Pahwa, MD, comment on therapeutic obstacles in treating OFF episodes and how to optimize the management of patients with Parkinson disease.

Rajesh Pahwa, MD, leads a discussion on approaching conversations about ON and OFF episodes in Parkinson disease throughout a patient’s treatment journey.

Rajesh Pahwa, MD; Robert A. Hauser, MD, MBA; and Laxman Bahroo, DO, provide insight on the challenges with motor and nonmotor symptoms of OFF episodes for patients with Parkinson Disease.

Drs Rajesh Pahwa, Robert A. Hauser, and Laxman Bahroo assess the awareness of OFF episodes in patients with Parkinson Disease and comment on improving education and awareness among non-neurology clinicians and other health care providers.

Rajesh Pahwa, MD; Laxman Bahroo, DO; and Robert A. Hauser, MD, MBA, examine the impact of OFF episodes on patients and their families’ quality of life and discuss goals of therapy for Parkinson Disease.

Robert A. Hauser, MD, MBA, discusses the appearance of OFF episodes throughout progression of Parkinson disease.

Laxman Bahroo, DO, and Rajesh Pahwa, MD, comment on the identification and presentation of OFF episodes in patients with Parkinson disease.

Robert A. Hauser, MD, MBA, and Rajesh Pahwa, MD, define the difference between ON time and OFF episodes for patients with Parkinson disease.

Rajesh Pahwa, MD, reviews the use of levodopa for the management of Parkinson disease symptoms.

Expert neurologists provide insight on unmet needs, challenges to improve access to care, and highlight clinical pearls for the management of OFF episodes in Parkinson disease.

Drs Laxman Bahroo and Sanjay Iyer comment on misconceptions and apprehensions surrounding the use of injectable therapies and the importance of patient education in this setting.

Laxman Bahroo, DO, and Sanjay Iyer, MD, discuss the efficacy and tolerability of subcutaneous and sublingual apomorphine and comment on patient selection for each formulation

Key opinion leaders in movement disorders evaluate the potential benefits and effect of an apomorphine infusion currently in development for the management of OFF episodes in Parkinson disease.